Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 151 AL 165

Curcuminoids and resveratrol as anti-Alzheimer agents

Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY.

Taiwan J Obstet Gynecol. 2012 Dec;51(4):515-25. doi: 10.1016/j.tjog.2012.09.005.

Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease

Christensen DD.

Postgrad Med. 2012 Nov;124(6):110-6. doi: 10.3810/pgm.2012.11.2589.

Review of drugs for Alzheimer's disease

Sun X, Jin L, Ling P.

Drug Discov Ther. 2012 Dec;6(6):285-90.

[Progress of researches on mechanisms of acupuncture intervention of Alzheimer's disease]

Zhu J, Guo HD, Shao SJ.

Zhen Ci Yan Jiu. 2012 Oct;37(5):422-7.

Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia

Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN.

J Pak Med Assoc. 2012 Jul;62(7):677-80.

The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease

Carroll JC, Rosario ER.

Curr Alzheimer Res. 2012 Jan;9(1):18-34. doi: 10.2174/156720512799015109.

Factors associated with caregivers' underestimation of quality of life in patients with Alzheimer's disease

Zhao H, Novella JL, Dramé M, Mahmoudi R, Barbe C, di Pollina L, Aquino JP, Pfitzenmeyer P, Rouaud O, George MY, Ankri J, Blanchard F, Jolly D.

Dement Geriatr Cogn Disord. 2012;33(1):11-7. doi: 10.1159/000333070. Epub 2012 Feb 22.

The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design

Andersen F, Viitanen M, Halvorsen DS, Straume B, Wilsgaard T, Engstad TA.

BMC Neurol. 2012 Jul 19;12:59. doi: 10.1186/1471-2377-12-59.

Antioxidant therapies for Alzheimer's disease

Feng Y, Wang X.

Oxid Med Cell Longev. 2012;2012:472932. doi: 10.1155/2012/472932. Epub 2012 Jul 25.

Study protocol: EXERcise and cognition in sedentary adults with early-ONset dementia (EXERCISE-ON)

Hooghiemstra AM, Eggermont LH, Scheltens P, van der Flier WM, Bakker J, de Greef MH, Koppe PA, Scherder EJ.

BMC Neurol. 2012 Aug 16;12:75. doi: 10.1186/1471-2377-12-75.

[Caring for young patients with Alzheimer's disease or associated disorders in day care centers of the Rhône-Alpes region]

Pongan É, Padovan C, Coste MH, Krolak-Salmon P, Rouch I.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep;10(3):343-8. doi: 10.1684/pnv.2012.0354.

What are the prospects of slowing the progression of Alzheimer's disease?

Palmer AM.

Drug Discov Today. 2012 Nov;17(21-22):1157-9. doi: 10.1016/j.drudis.2012.09.009. Epub 2012 Oct 2.

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes

Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C.

Drugs Aging. 2012 Oct;29(10):793-806. doi: 10.1007/s40266-012-0012-5.

Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study

Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias